American journal of lifestyle medicine · 2025
Sleep Quality in Patients With Type 2 Diabetes Mellitus.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Khamassi Sana, Bornaz Emna, Abdesselem Haifa, Ounaissa Kamilia, Boukhayatia Fatma, Amrouche Chiraz
Аннотация
BACKGROUND: Research on sleep disorders has gained significant attention in recent years, particularly within the diabetic population. This study aimed to assess sleep quality in patients with T2D and identify the factors associated with poor sleep quality.
METHODS: We conducted a cross-sectional descriptive observational study including adult patients with T2D. Sleep data were collected using the Pittsburgh Sleep Quality Index (PSQI) to assess the sleep quality.
RESULTS: A total of 156 patients were recruited with a mean age of 57.04 ± 9.49 years. The mean duration of diabetes was 13.12 ± 8.14 years. The mean total PSQI score was 8.42 ± 4.02, and poor sleep quality was observed in 70.5% of the study population. Our study revealed a significant association between poor sleep quality and diabetic neuropathy (P = 0.03), low levels of HDL cholesterol (P = 0.008) as well as the use of sulfonylurea (P = 0.02). The total PSQI score was positively correlated with the DN4 score (P = 0.04) and inversely correlated with the daily physical activity score (P = 0.019) as well as the total score of Ricci and Gagnon (P = 0.02). Poor sleep quality was independently associated with sulfonylurea use (P = 0.037; OR = 5.27).
CONCLUSION: Our study highlights the importance of integrating sleep management into the care of diabetic patients.
METHODS: We conducted a cross-sectional descriptive observational study including adult patients with T2D. Sleep data were collected using the Pittsburgh Sleep Quality Index (PSQI) to assess the sleep quality.
RESULTS: A total of 156 patients were recruited with a mean age of 57.04 ± 9.49 years. The mean duration of diabetes was 13.12 ± 8.14 years. The mean total PSQI score was 8.42 ± 4.02, and poor sleep quality was observed in 70.5% of the study population. Our study revealed a significant association between poor sleep quality and diabetic neuropathy (P = 0.03), low levels of HDL cholesterol (P = 0.008) as well as the use of sulfonylurea (P = 0.02). The total PSQI score was positively correlated with the DN4 score (P = 0.04) and inversely correlated with the daily physical activity score (P = 0.019) as well as the total score of Ricci and Gagnon (P = 0.02). Poor sleep quality was independently associated with sulfonylurea use (P = 0.037; OR = 5.27).
CONCLUSION: Our study highlights the importance of integrating sleep management into the care of diabetic patients.